Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01648491 · ClinicalTrials.gov registry record · NA
Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use
A NA study, sponsored by Kenneth Peters, MD.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01648491: Completed NA study, sponsored by Kenneth Peters, MD.
NCT01648491 is a NA study that has completed, run by Kenneth Peters, MD. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01648491, a NA study, has completed, sponsored by Kenneth Peters, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.
Interventions
- PROCEDURE Muscle Biopsy
- BIOLOGICAL Injection of autologous stem cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-10 |
| Est. Completion | 2016-01 |
| Phase | NA |
What the finished NCT01648491 record still lists
NCT01648491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Muscle Biopsy is the first listed.
NCT01648491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01648491 about?
NCT01648491 is a clinical study titled "Autologous Stem Cells for Urinary Incontinence: Single Patient Compassionate Use". Determine safety and effectiveness of the technique using autologous stem cells in the treatment of urinary incontinence in one male subject.
What is the current status of trial NCT01648491?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2011-10. Estimated completion is 2016-01.
What interventions are being tested in trial NCT01648491?
The interventions under investigation include: Muscle Biopsy (PROCEDURE), Injection of autologous stem cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT01648491?
This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01648491's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia